These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 26449448)
41. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Tessari L; Cavezzi A; Frullini A Dermatol Surg; 2001 Jan; 27(1):58-60. PubMed ID: 11231246 [TBL] [Abstract][Full Text] [Related]
42. Stroke after varicose vein foam injection sclerotherapy. Forlee MV; Grouden M; Moore DJ; Shanik G J Vasc Surg; 2006 Jan; 43(1):162-4. PubMed ID: 16414404 [TBL] [Abstract][Full Text] [Related]
43. Incidence of side effects using carbon dioxide-oxygen foam for chemical ablation of superficial veins of the lower extremity. Morrison N; Neuhardt DL; Rogers CR; McEown J; Morrison T; Johnson E; Salles-Cunha SX Eur J Vasc Endovasc Surg; 2010 Sep; 40(3):407-13. PubMed ID: 20547080 [TBL] [Abstract][Full Text] [Related]
44. Comparison of 1% and 3% polidocanol foam in ultrasound guided sclerotherapy of the great saphenous vein: a randomised, double-blind trial with 2 year-follow-up. "The 3/1 Study". Hamel-Desnos C; Ouvry P; Benigni JP; Boitelle G; Schadeck M; Desnos P; Allaert FA Eur J Vasc Endovasc Surg; 2007 Dec; 34(6):723-9; discussion 730. PubMed ID: 17884623 [TBL] [Abstract][Full Text] [Related]
46. Should foam made with physiologic gases be the standard in sclerotherapy? Wong M Phlebology; 2015 Oct; 30(9):580-6. PubMed ID: 25392457 [TBL] [Abstract][Full Text] [Related]
47. Blocking the saphenofemoral junction during ultrasound-guided foam sclerotherapy-- assessment of a presumed safety-measure procedure. Ceulen RP; Jagtman EA; Sommer A; Teule GJ; Schurink GW; Kemerink GJ Eur J Vasc Endovasc Surg; 2010 Dec; 40(6):772-6. PubMed ID: 20926321 [TBL] [Abstract][Full Text] [Related]
48. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Cavezzi A; Tessari L Phlebology; 2009 Dec; 24(6):247-51. PubMed ID: 19952380 [TBL] [Abstract][Full Text] [Related]
50. Infusion of foam sclerosants results in a distance-dependent procoagulant activity, haemoconcentration and elevation of D-dimer levels. Connor DE; Joseph JE; Exner T; Ma DD; Parsi K Phlebology; 2014 Dec; 29(10):677-87. PubMed ID: 24002013 [TBL] [Abstract][Full Text] [Related]
51. Effectiveness and safety of ultrasound-guided foam sclerotherapy for recurrent varicose veins: immediate results. Kakkos SK; Bountouroglou DG; Azzam M; Kalodiki E; Daskalopoulos M; Geroulakos G J Endovasc Ther; 2006 Jun; 13(3):357-64. PubMed ID: 16784324 [TBL] [Abstract][Full Text] [Related]
52. Venous gas embolism during foam sclerotherapy of saphenous veins despite recommended treatment modifications. Parsi K Phlebology; 2011 Jun; 26(4):140-7. PubMed ID: 21087951 [TBL] [Abstract][Full Text] [Related]
53. Surfactant foam technology for in situ removal of heavy chlorinated compounds-DNAPLs. Maire J; Coyer A; Fatin-Rouge N J Hazard Mater; 2015 Dec; 299():630-8. PubMed ID: 26291781 [TBL] [Abstract][Full Text] [Related]
54. 1064 nm Nd:YAG long pulse laser after polidocanol microfoam injection dramatically improves the result of leg vein treatment: a randomized controlled trial on 517 legs with a three-year follow-up. Moreno-Moraga J; Smarandache A; Pascu ML; Royo J; Trelles MA Phlebology; 2014 Dec; 29(10):658-66. PubMed ID: 23989971 [TBL] [Abstract][Full Text] [Related]
55. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Barrett JM; Allen B; Ockelford A; Goldman MP Dermatol Surg; 2004 Nov; 30(11):1386-90. PubMed ID: 15522019 [TBL] [Abstract][Full Text] [Related]
57. The risk of bacteria in foam sclerotherapy: does the condition of the air in outpatient vs. operating rooms make a difference? Chen J; Liu YR; Sun YD; Liu C; Zhuo SY; Li K; Wei FC; Liu SH Br J Dermatol; 2014 Dec; 171(6):1386-90. PubMed ID: 24807810 [TBL] [Abstract][Full Text] [Related]
58. Foam sclerosants are more stable at lower temperatures. Valenzuela GC; Wong K; Connor DE; Behnia M; Parsi K Eur J Vasc Endovasc Surg; 2013 Nov; 46(5):593-9. PubMed ID: 24070851 [TBL] [Abstract][Full Text] [Related]
59. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients. Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126 [TBL] [Abstract][Full Text] [Related]
60. An Investigation on the Influence of Hyaluronic Acid on Polidocanol Foam Stability. Chen AW; Liu YR; Li K; Liu SH Dermatol Surg; 2016 Jan; 42(1):56-8. PubMed ID: 26671207 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]